Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 4/4/2020
SIETES contiene 92956 citas

 
 
 1 a 20 de 23 siguiente >>
Presentar resultados
Seleccionar todas
2. Cita con resumen
Bajaj JS, Zadvornova Y, Heuman DM, Hafeezullah M, Hoffmann RG, Sanyal AJ, Saeian K. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am J Gastroenterol 2009;104:1130-4. [Ref.ID 85841]
3.
Farjah F, Flum DR. When not being superior may not be good enough. JAMA 2007;298:924-5. [Ref.ID 80914]
4.Tiene citas relacionadas Cita con resumen
Martis L, Verger C, Owen Jr WF. Aseptic peritonitis due to peptidoglycan. Authors' reply. Lancet 2005;366:290. [Ref.ID 74507]
5.Tiene citas relacionadas Cita con resumen
Goffin E, Tintillier M, Devuyst O. Aseptic peritonitis due to peptidoglycan. Lancet 2005;366:289-90. [Ref.ID 74506]
6. Cita con resumen
Brain EGC, Bachelot T, Serin D, Kirscher S, Eymard JC, Extra JM, Combe M, Fourme E, Noguès C, Rouëssé J, for the RAPP-01 Trial Investigators. Life-threatening sepsis associated with adjuvant doxorubicin plus docetaxel for intermediate-risk breast cancer. JAMA 2005;293:2367-71. [Ref.ID 73801]
7.Tiene citas relacionadas Cita con resumen
Martis L, Patel M, Giertych J, Mongoven J, Taminne M, Perrier M A, Mendoza O, Goud N, Costigan A, Denjoy N, Verger C, Owen Jr WF. Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution. Lancet 2005;365:588-94. [Ref.ID 72923]
8.
Arzuaga A, Maynar J, Gascón AR, Isla A, Corral E, Fonseca F, Sánchez-Izquierdo JA, Rello J, Canut A, Pedraz J L. Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration. J Clin Pharmacol 2005;45:168-76. [Ref.ID 72595]
9.
Ginés P, Cárdenas A, Arroyo V, Rodés J. Management of cirrhosis and ascites. N Engl J Med 2004;350:1646-54. [Ref.ID 69758]
10.
Nguyen N, Spadari M, Ruiz J-M, Camprasse MA, Galinier A, Jean-Pastor M-J, Valli M. Péritonite sous buprénorphine haut dosage (Subutex): à propos d'un cas. Therapie 2003;58:469-70. [Ref.ID 67986]
11.
Frampton JE, Plosker G L. Icodextrin: a review of its use in peritoneal dialysis. Drugs 2003;63:2079-105. [Ref.ID 67616]
12.
Soares-Weiser K, Paul M, Brezis M, Leibovici L. Antibiotic treatment for spontaneous bacterial peritonitis. BMJ 2002;324:100-2. [Ref.ID 60125]
13.
Crowley B. Antibiotic therapy and peritonitis. Lancet 2001;357:396. [Ref.ID 58220]
14.
Krige JEJ, Beckingham IJ. Portal hypertension - 2. Ascites, encephalopathy, and other conditions. BMJ 2001;322:416-8. [Ref.ID 55296]
15.
Hauer KE, Winawer N. Update in hospital medicine. Ann Intern Med 2000;133:707-9. [Ref.ID 53787]
16.
Cohen J. Combination antibiotic therapy for severe peritonitis. Lancet 2000;356:1539-40. [Ref.ID 53540]
17.
Adrogué HJ, Madias NE. Hyponatremia. BMJ 2000;320:1581-9. [Ref.ID 51071]
18.
Runyon B A. Albumin infusion for spontaneous bacterial peritonitis. Lancet 1999;354:1838-9. [Ref.ID 48308]
19.Tiene citas relacionadas
Bass NM. Intravenous albumin for spontaneous bacterial peritonitis in patients with cirrhosis. N Engl J Med 1999;341:443-4. [Ref.ID 46042]
20.Tiene citas relacionadas Cita con resumen
Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Ginés P, Rodés J. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:403-9. [Ref.ID 46038]
Seleccionar todas
 
 1 a 20 de 23 siguiente >>